Circulating Tumor DNA Analysis Detects Minimal Residual Disease and Predicts Recurrence in Patients With Stage II Colon Cancer
Science Translational Medicine - United States
doi 10.1126/scitranslmed.aaf6219
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 6, 2016
Authors
Publisher
American Association for the Advancement of Science (AAAS)